Is ambulatory flexible ureteroscopic lithotripsy safe and feasible? evidence from a propensity score–matched cohort

To evaluate the safety, efficacy, and health economic value of flexible ureteroscopic lithotripsy (fURS) for upper urinary tract stones in ambulatory surgery compared to traditional inpatient management. A retrospective cohort study analyzed 174 fURS cases performed by a single surgeon between January and December 2024. Patients were divided into ambulatory and inpatient groups. Propensity score matching (PSM, 1:1 ratio) was applied to balance baseline differences. Demographic data, perioperative parameters, and outcomes including stone-free rate (SFR, assessment via abdominal X-ray within 24 h postoperatively, with residual fragments > 2 mm considered significant), complication rates (Clavien-Dindo classification), hospitalization duration, and costs were analyzed. A total of 174 patients with upper urinary tract stones were included. Pre-matching analysis revealed that the inpatient group had significantly older age (58.55 ± 12.52 vs. 50.14 ± 12.79 years, P < 0.001), larger cumulative stone diameter (1.67 ± 0.74 vs. 1.34 ± 0.57 cm, P = 0.001), and longer operative time (53.09 ± 26.64 vs. 41.30 ± 21.45 min, P = 0.002). No significant differences were observed in postoperative complications (2.33% vs. 1.14%, P = 0.491) or SFR (80.23% vs. 82.95%, P = 0.789). The ambulatory group demonstrated a 74.6% reduction in hospitalization duration (1.09 ± 0.29 vs. 4.29 ± 1.14 days, P < 0.001) and lower unadjusted total costs (27,075.41 ± 4,112.93 vs. 29,240.94 ± 3,856.12 RMB, P < 0.001). Post-PSM analysis confirmed comparable baseline characteristics, with the ambulatory group maintaining shorter hospitalization (1.12 ± 0.33 vs. 4.18 ± 1.09 days, P < 0.001), with no statistically significant difference in total costs between the two groups (27,378.33 ± 3768.93 vs. 28,639.67 ± 4,033.38 RMB, P = 0.106). Ambulatory fURS represents a safe and effective treatment option for selected patients with upper urinary tract stones. This model substantially reduces hospitalization duration without compromising surgical outcomes or patient safety in carefully selected patients treated by experienced surgeons.

Authors

Institutions

Publication Details

Journal
BMC Urology
Published
2026-04-06
DOI
https://doi.org/10.1186/s12894-026-02129-x
Primary Topic
Kidney Stones and Urolithiasis Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Is ambulatory flexible ureteroscopic lithotripsy safe and feasible? evidence from a propensity score–matched cohort

Junjun Xu, Jie Gu, Lianming Wang, Liulin Xiong et al.
BMC Urology
Kidney Stones and Urolithiasis Treatments
article

Is ambulatory flexible ureteroscopic lithotripsy safe and feasible? evidence from a propensity score–matched cohort

Junjun Xu, Jie Gu, Lianming Wang, Liulin Xiong, Jun Liu, Tao Xu, Hao Hu, Bo Yang, Cong Tian
article en

Abstract

To evaluate the safety, efficacy, and health economic value of flexible ureteroscopic lithotripsy (fURS) for upper urinary tract stones in ambulatory surgery compared to traditional inpatient management. A retrospective cohort study analyzed 174 fURS cases performed by a single surgeon between January and December 2024. Patients were divided into ambulatory and inpatient groups. Propensity score matching (PSM, 1:1 ratio) was applied to balance baseline differences. Demographic data, perioperative parameters, and outcomes including stone-free rate (SFR, assessment via abdominal X-ray within 24 h postoperatively, with residual fragments > 2 mm considered significant), complication rates (Clavien-Dindo classification), hospitalization duration, and costs were analyzed. A total of 174 patients with upper urinary tract stones were included. Pre-matching analysis revealed that the inpatient group had significantly older age (58.55 ± 12.52 vs. 50.14 ± 12.79 years, P < 0.001), larger cumulative stone diameter (1.67 ± 0.74 vs. 1.34 ± 0.57 cm, P = 0.001), and longer operative time (53.09 ± 26.64 vs. 41.30 ± 21.45 min, P = 0.002). No significant differences were observed in postoperative complications (2.33% vs. 1.14%, P = 0.491) or SFR (80.23% vs. 82.95%, P = 0.789). The ambulatory group demonstrated a 74.6% reduction in hospitalization duration (1.09 ± 0.29 vs. 4.29 ± 1.14 days, P < 0.001) and lower unadjusted total costs (27,075.41 ± 4,112.93 vs. 29,240.94 ± 3,856.12 RMB, P < 0.001). Post-PSM analysis confirmed comparable baseline characteristics, with the ambulatory group maintaining shorter hospitalization (1.12 ± 0.33 vs. 4.18 ± 1.09 days, P < 0.001), with no statistically significant difference in total costs between the two groups (27,378.33 ± 3768.93 vs. 28,639.67 ± 4,033.38 RMB, P = 0.106). Ambulatory fURS represents a safe and effective treatment option for selected patients with upper urinary tract stones. This model substantially reduces hospitalization duration without compromising surgical outcomes or patient safety in carefully selected patients treated by experienced surgeons.

BMC Urology
Peking University (CN), Qingzhou City People's Hospital (CN), Peking University People's Hospital (CN)
Zero hunger
Openalex Percentile: Top 6%
Kidney Stones and Urolithiasis Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.